Radiation potentiating effect of ethyl bis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
D000818:Animals; D001388:Aziridines / Q000008:administration & dosage / Q000494:pharmacology*; D001389:Azirines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D005260:Female; D007941:Leukemia P388 / Q000532:radiotherapy*; D007942:Leukemia, Experimental / Q000532:radiotherapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D011838:Radiation-Sensitizing Agents; D011867:Radioisotope Teletherapy; D013997:Time Factors
D001388:Aziridines; D001389:Azirines; D011838:Radiation-Sensitizing Agents; C001181:AB 163